• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与新型冠状病毒肺炎相关的多系统炎症综合征(MIS-C)患儿入住儿科重症监护病房相关的临床和实验室参数

Clinical and Laboratory Parameters Associated with PICU Admission in Children with Multisystem Inflammatory Syndrome Associated with COVID-19 (MIS-C).

作者信息

Dourdouna Maria-Myrto, Mpourazani Evdoxia, Tatsi Elizabeth-Barbara, Tsirogianni Chrysanthi, Barbaressou Charikleia, Dessypris Nick, Michos Athanasios

机构信息

First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.

Pediatric Intensive Care Unit, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.

出版信息

J Pers Med. 2024 Sep 23;14(9):1011. doi: 10.3390/jpm14091011.

DOI:10.3390/jpm14091011
PMID:39338265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11432765/
Abstract

Multisystem Inflammatory Syndrome in children (MIS-C) is a rare but severe post-infectious complication of COVID-19 that often requires admission to the Pediatric Intensive Care Unit (PICU). The present study aimed to compare the demographic, clinical, and laboratory characteristics of children diagnosed with MIS-C who were admitted to the PICU and those who did not require PICU admission. Children diagnosed with MIS-C from September 2020 to April 2023 were included in this case-control study. Demographic, clinical, and laboratory data were collected from medical records. Fifty children with MIS-C were included in the study [median (IQR) age: 7.5 (4.3, 11.4) years, 28/50 (56%) males]. Twenty-two (22/50, 44%) children required admission to the PICU. In the multivariate regression analysis, hepatic (OR: 12.89, 95%CI: 1.35-123.41, -value = 0.03) and cardiological involvement (OR: 34.55, 95%CI: 2.2-541.91, -value = 0.01) were significantly associated with hospitalization at the PICU. Regarding the laboratory and imaging parameters during the first 48 h from admission, D-dimer levels higher than 4 μg/mL and decreased Left Ventricular Ejection Fraction (LVEF) were associated with an increased risk of PICU admission (OR: 7.95, 95%CI: 1.48-42.78, -value = 0.02 and OR = 1.28, 95%CI: 1.07-1.53, -value = 0.01). Children who were admitted to the PICU were more likely to develop complications during their hospitalization (10/22, 45.5% vs. 3/28, 10.7%, -value = 0.005) and were hospitalized for more days than children in the pediatric ward (median length of stay (IQR): 20 (15, 28) days vs. 8.5 (6, 14) days, -value < 0.001). The findings of this study indicate that cardiovascular and hepatic involvement and increased D-dimer levels in children with MIS-C might be associated with admission to the PICU.

摘要

儿童多系统炎症综合征(MIS-C)是新型冠状病毒肺炎(COVID-19)一种罕见但严重的感染后并发症,常需入住儿科重症监护病房(PICU)。本研究旨在比较入住PICU的MIS-C确诊儿童与无需入住PICU的儿童的人口统计学、临床和实验室特征。本病例对照研究纳入了2020年9月至2023年4月确诊为MIS-C的儿童。从病历中收集人口统计学、临床和实验室数据。50例MIS-C儿童纳入研究[年龄中位数(四分位间距):7.5(4.3,11.4)岁,28/50(56%)为男性]。22例(22/50,44%)儿童需要入住PICU。在多因素回归分析中,肝脏受累(比值比:12.89,95%置信区间:1.35 - 123.41,P值 = 0.03)和心脏受累(比值比:34.55,95%置信区间:2.2 - 541.91,P值 = 0.01)与入住PICU显著相关。关于入院后最初48小时内的实验室和影像学参数,D - 二聚体水平高于4μg/mL和左心室射血分数(LVEF)降低与入住PICU的风险增加相关(比值比:7.95,95%置信区间:1.48 - 42.78,P值 = 0.02;比值比 = 1.28,95%置信区间:1.07 - 1.53,P值 = 0.01)。入住PICU的儿童在住院期间更易发生并发症(10/22,45.5% vs. 3/28,10.7%,P值 = 0.005),且住院天数比儿科病房的儿童更多(住院时间中位数(四分位间距):20(15,28)天 vs. 8.5(6,14)天,P值 < 0.001)。本研究结果表明,MIS-C儿童的心血管和肝脏受累以及D - 二聚体水平升高可能与入住PICU有关。

相似文献

1
Clinical and Laboratory Parameters Associated with PICU Admission in Children with Multisystem Inflammatory Syndrome Associated with COVID-19 (MIS-C).与新型冠状病毒肺炎相关的多系统炎症综合征(MIS-C)患儿入住儿科重症监护病房相关的临床和实验室参数
J Pers Med. 2024 Sep 23;14(9):1011. doi: 10.3390/jpm14091011.
2
A Comparative Study of Children with MIS-C between Admitted to the Pediatric Intensive Care Unit and Pediatric Ward: A One-Year Retrospective Study.儿童川崎病合并巨噬细胞活化综合征患儿在重症监护病房与普通病房住院的比较研究:一项为期一年的回顾性研究。
J Trop Pediatr. 2021 Dec 8;67(6). doi: 10.1093/tropej/fmab104.
3
Clinical manifestations and outcomes associated with PICU admission in children with multisystem inflammatory syndrome in Taiwan: A retrospective cohort study.台湾儿童多系统炎症综合征患者入住儿科重症监护病房的临床表现和结局:一项回顾性队列研究。
Int J Rheum Dis. 2024 Jan;27(1):e14970. doi: 10.1111/1756-185X.14970. Epub 2023 Nov 10.
4
Risk Factors Associated with Intensive Care Admission in Children with Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome (MIS-C) in Latin America: A Multicenter Observational Study of the REKAMLATINA Network.与儿童严重急性呼吸综合征冠状病毒 2 相关的多系统炎症综合征 (MIS-C) 相关的重症监护入院风险因素:REKAMLATINA 网络的一项多中心观察性研究。
J Intensive Care Med. 2024 Aug;39(8):785-793. doi: 10.1177/08850666241233189. Epub 2024 Feb 28.
5
Levels of Complement Components in Children With Acute COVID-19 or Multisystem Inflammatory Syndrome.急性 COVID-19 或多系统炎症综合征患儿补体成分水平。
JAMA Netw Open. 2023 Mar 1;6(3):e231713. doi: 10.1001/jamanetworkopen.2023.1713.
6
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.儿童和青少年中严重的 SARS-CoV-2 表现:从 COVID-19 肺炎到多系统炎症综合征:西班牙儿科重症监护病房的一项多中心研究。
Crit Care. 2020 Nov 26;24(1):666. doi: 10.1186/s13054-020-03332-4.
7
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series Experience in a Tertiary Care Hospital of Southern Turkey.儿童多系统炎症综合征(MIS-C)与 COVID-19 相关:土耳其南部一家三级保健医院的病例系列经验。
J Trop Pediatr. 2021 May 17;67(2). doi: 10.1093/tropej/fmab050.
8
The Role of Therapeutic Plasma Exchange (TPE) in Multisystem Inflammatory Syndrome in Children (MIS-C).治疗性血浆置换(TPE)在儿童多系统炎症综合征(MIS-C)中的作用。
Children (Basel). 2021 Jun 11;8(6):498. doi: 10.3390/children8060498.
9
Severe Multi-inflammatory Syndrome in Children Temporally Related to COVID 19-Clinical Course, Laboratory Profile and Outcomes from a North Indian PICU.与 COVID-19 相关的严重儿童多系统炎症综合征-来自印度北部 PICU 的临床过程、实验室特征和结局。
J Intensive Care Med. 2022 Sep;37(9):1229-1237. doi: 10.1177/08850666221092302. Epub 2022 Apr 26.
10
Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome.符合巨噬细胞活化综合征分类标准的儿童多系统炎症综合征的临床特征
Front Pediatr. 2022 Sep 15;10:981711. doi: 10.3389/fped.2022.981711. eCollection 2022.

本文引用的文献

1
Severity predictors for multisystemic inflammatory syndrome in children after SARS-CoV-2 infection in Vietnam.越南 SARS-CoV-2 感染后儿童多系统炎症综合征的严重程度预测因素。
Sci Rep. 2024 Jul 9;14(1):15810. doi: 10.1038/s41598-024-66891-4.
2
Clinical and Laboratory Biomarkers as Predictors of Severity in Pediatric Inflammatory Multisystem Syndrome-temporally Associated With SARS-CoV-2: Data From a Prospective Nationwide Surveillance Study in Switzerland.临床和实验室生物标志物可预测与 SARS-CoV-2 相关的儿童炎症性多系统综合征的严重程度:来自瑞士全国前瞻性监测研究的数据。
Pediatr Infect Dis J. 2024 Jul 1;43(7):675-681. doi: 10.1097/INF.0000000000004332. Epub 2024 Mar 20.
3
Risk Factors Associated with Intensive Care Admission in Children with Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome (MIS-C) in Latin America: A Multicenter Observational Study of the REKAMLATINA Network.与儿童严重急性呼吸综合征冠状病毒 2 相关的多系统炎症综合征 (MIS-C) 相关的重症监护入院风险因素:REKAMLATINA 网络的一项多中心观察性研究。
J Intensive Care Med. 2024 Aug;39(8):785-793. doi: 10.1177/08850666241233189. Epub 2024 Feb 28.
4
Baseline Echocardiography and Laboratory Findings in MIS-C and Associations with Clinical Illness Severity.MIS-C 的基线超声心动图和实验室检查结果及其与临床疾病严重程度的关系。
Pediatr Cardiol. 2024 Mar;45(3):560-569. doi: 10.1007/s00246-023-03394-5. Epub 2024 Jan 28.
5
Clinical manifestations and outcomes associated with PICU admission in children with multisystem inflammatory syndrome in Taiwan: A retrospective cohort study.台湾儿童多系统炎症综合征患者入住儿科重症监护病房的临床表现和结局:一项回顾性队列研究。
Int J Rheum Dis. 2024 Jan;27(1):e14970. doi: 10.1111/1756-185X.14970. Epub 2023 Nov 10.
6
Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease During the COVID-19 Pandemic.新冠大流行期间 MIS-C 和川崎病的流行病学和疾病严重程度。
Pediatrics. 2023 Nov 1;152(5). doi: 10.1542/peds.2023-062101.
7
Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.儿童新型冠状病毒肺炎相关多系统炎症综合征严重危及生命病程的危险因素判定
Children (Basel). 2023 Aug 9;10(8):1366. doi: 10.3390/children10081366.
8
"Multisystem Inflammatory Syndrome in Children" (MIS-C) after COVID-19 Infection in the Metropolitan Area of Nuremberg-Erlangen, Germany-Expectations and Results of a Two-Year Period.德国纽伦堡 - 埃尔朗根都会区新冠病毒感染后儿童多系统炎症综合征(MIS-C):两年期间的预期与结果
Children (Basel). 2023 Aug 9;10(8):1363. doi: 10.3390/children10081363.
9
Multi-Inflammatory Syndrome in Children (MIS-C) in 2023: Is It Time to Forget about It?2023年儿童多炎症综合征(MIS-C):是时候将其抛诸脑后了吗?
Children (Basel). 2023 May 31;10(6):980. doi: 10.3390/children10060980.
10
Multisystem Inflammatory Syndrome in Children: Two Years' Worth of Learning.儿童多系统炎症综合征:两年的学习成果。
Clin Pediatr (Phila). 2024 Jan;63(1):40-46. doi: 10.1177/00099228231180411. Epub 2023 Jun 13.